Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells
Open accessAbstract
UNLABELLED: Cholestasis leads to liver cell death, fibrosis, cirrhosis, and eventually liver failure. Despite limited benefits, ursodeoxycholic acid (UDCA) is the only Food and Drug Administration-approved treatment for cholestatic disorders. Retinoic acid (RA) is a ligand for nuclear receptors that modulate bile salt homeostasis. RA also possesses immunomodulatory effects and is used to treat acute promyelocytic leukemia and inflammatory disorders such as psoriasis, acne, and rheumatoid arthritis. To test whether the supplementation of RA with UDCA is superior to UDCA alone for treating cholestasis, male Sprague-Dawley rats underwent common bile duct ligation (BDL) for 14 days and were treated with phosphate-buffered saline (PBS), UDCA, all-trans retinoic acid (atRA), or UDCA and atRA by gavage. Treatment with UDCA and atRA substantially improved animal growth rates, significantly reduced liver fibrosis and bile duct proliferation, and nearly eliminated liver necrosis after BDL. Reductions in the bile salt pool size and liver hydroxyproline content were also seen with treatment with atRA or atRA and UDCA versus PBS and UDCA. Furthermore, atRA and UDCA significantly reduced liver messenger RNA and/or protein expression of transforming growth factor β1 (Tgf-β1), collagen 1a1 (Col1A1), matrix metalloproteinase 2 (Mmp2), cytokeratin 19, α-smooth muscle actin (α-SMA), cytochrome P450 7A1 (Cyp7a1), tumor necrosis factor α, and interleukin-β1. The molecular mechanisms of this treatment were also assessed in human hepatocytes, hepatic stellate cells, and LX-2 cells. atRA alone or in combination with UDCA greatly repressed CYP7A1 expression in human hepatocytes and significantly inhibited COL1A1, MMP2, and α-SMA expression and/or activity in primary human hepatic stellate cells and LX-2 cells. Furthermore, atRA reduced TGF-β1-induced Smad2 phosphorylation in LX-2 cells. CONCLUSION: Our findings indicate that the addition of RA to UDCA reduces the bile salt pool size and liver fibrosis and might be an effective supplemental therapy with UDCA for cholestatic diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Administration of atRAs in vitro to HSCs and in vivo in cholestatic animal models is linked to inhibition of pro-fibrotic gene expression such as TGF-β, col1α1, αSMA and MMP-2, and to protective properties regarding ECM accumulation.
“the administration of atRAs in vitro to HSCs and in vivo in cholestatic animal models was linked to an inhibition of pro-fibrotic gene expression (TGF-β, col1α1, αSMA, and MMP-2) [179][180][181][182] and showed protective properties in regard to ECM accumulation.[183][184][185]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [180]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,015 · see citing works
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,567 · see citing works
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J. A., Medina, J. C., Li, L., Lustig, K. D., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,303 · see citing works
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241 · see citing works
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,217 · see citing works
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144 · see citing works
Quantitative Zymography: Detection of Picogram Quantities of Gelatinases
Kleiner, D. E., & Stetler‐Stevenson, W. G. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1186 · Cited by 866 · see citing works
(2015) · Elsevier eBooks · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 815 · see citing works
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720 · see citing works
Schuetz, E. G., Strom, S. C., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J. K., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 395 · see citing works
Bile acids: regulation of apoptosis by ursodeoxycholic acid
Amaral, J. D., Viana, R. J. S., Ramalho, R. M., Steer, C. J., & Rodrigues, C. M. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900011-jlr200 · Cited by 360 · see citing works
Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 312 · see citing works
Friedman, S. L., Rockey, D. C., McGuire, R. F., Maher, J. J., Boyles, J. K., & Yamasaki, G. (1992) · Hepatology · doi:10.1002/hep.1840150211 · Cited by 284 · see citing works
Portal fibroblasts: Underappreciated mediators of biliary fibrosis†
Dranoff, J. A., & Wells, R. G. (2010) · Hepatology · doi:10.1002/hep.23405 · Cited by 273 · see citing works
Casini, A., Pinzani, M., Milani, S., Grappone, C., Galli, G., Jézéquel, A. M., Schuppan, D., Rotella, C. M., & Surrenti, C. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90033-9 · Cited by 225 · see citing works
Liu, C., Gaça, M., Swenson, E. S., Vellucci, V. F., Reiß, M., & Wells, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207728200 · Cited by 186 · see citing works
Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis
Mennone, A., Soroka, C. J., Cai, S., Harry, K., Adachi, M., Hagey, L. R., Schuetz, J. D., & Boyer, J. L. (2006) · Hepatology · doi:10.1002/hep.21158 · Cited by 179 · see citing works
Self-citationHohenester, S. D., Elferink, R. P. J. O., & Beuers, U. H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0164-5 · Cited by 176 · see citing works
Myofibroblast – like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario
Parola, M., Marra, F., & Pinzani, M. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.002 · Cited by 169 · see citing works
Reichrath, J., Lehmann, B., Carlberg, C., Varani, J., & Zouboulis, C. C. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-958715 · Cited by 164 · see citing works
Svegliati‐Baroni, G., Ridolfi, F., Hannivoort, R. A., Saccomanno, S., Buist‐Homan, M., Minicis, S. D., Jansen, P. L. M., Candelaresi, C., Benedetti, A., & Moshage, H. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.007 · Cited by 162 · see citing works
Davis, B. H., Kramer, R. T., & Davidson, N. O. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114943 · Cited by 148 · see citing works
Poncelet, A.-C., de Caestecker, M. P., & Schnaper, H. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00680.x · Cited by 147 · see citing works
Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids
Hellemans, K., Verbuyst, P., Quartier, E., Schuit, F., Rombouts, K., Chandraratna, R. A. S., Schuppan, D., & Geerts, A. (2004) · Hepatology · doi:10.1002/hep.20015 · Cited by 102 · see citing works
Cai, S., He, H., Nguyen, T., Mennone, A., & Boyer, J. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m005546 · Cited by 85 · see citing works
Self-citationSoroka, C. J., Mennone, A., Hagey, L. R., Ballatori, N., & Boyer, J. L. (2009) · Hepatology · doi:10.1002/hep.23265 · Cited by 80 · see citing works
Self-citationUrsodeoxycholic acid treatment of vanishing bile duct syndromes
Pusl, T. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i22.3487 · Cited by 76 · see citing works
Noncanonical transforming growth factor β signaling in scleroderma fibrosis
Trojanowska, M. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833038ce · Cited by 65 · see citing works
Hisamori, S., Tabata, C., Kadokawa, Y., Okoshi, K., Tabata, R., Mori, A. S., Nagayama, S., Watanabe, G., Kubo, H., & Sakai, Y. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01745.x · Cited by 61 · see citing works
Kawata, K., Kobayashi, Y., Souda, K., Kawamura, K., Sumiyoshi, S., Takahashi, Y., Noritake, H., Watanabe, S., Suehiro, T., & Nakamura, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2903 · Cited by 58 · see citing works
Rossen, E. V., Borght, S. V., van Grunsven, L. A., Reynaert, H., Bruggeman, V., Blomhoff, R., Roskams, T., & Geerts, A. E. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0544-2 · Cited by 53 · see citing works
Phenotypical modulation of liver fat-storing cells by retinoids
Pinzani, M., Geñtilini, P., & Hanna, E. A. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90160-q · Cited by 51 · see citing works
Bellentani, S. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200502000-00001 · Cited by 47 · see citing works
Ursodeoxycholic Acid Treatment of Vanishing Bile Duct Syndromes
Rust, C., & Beuers, U. H. (2020) · CRC Press eBooks · doi:10.1201/9780367813888-33 · Cited by 42 · see citing works
Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
Montrone, M., Martorelli, D., Rosato, A., & Dolcetti, R. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009788452435 · Cited by 37 · see citing works
Treatment of Primary Biliary Cirrhosis: Therapy with Choleretic and Immunosuppressive Agents
Silveira, M. G., & Lindor, K. D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.008 · Cited by 27 · see citing works
Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats
Wang, H., Dan, Z., & Jiang, H. (2008) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-008-0514-x · Cited by 25 · see citing works
Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
Zein, C. O., & Lindor, K. D. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0079-2 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120035 · Cited by 783 · see citing works
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.052 · Cited by 436 · see citing works
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 384 · see citing works
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Cai, B., Dongiovanni, P., Corey, K. E., Wang, X., Shmarakov, I. O., Zheng, Z., Kasikara, C., Davra, V., Meroni, M., Chung, R. T., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.013 · Cited by 266 · see citing works
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 234 · see citing works
Anti-fibrogenic strategies and the regression of fibrosis
Kisseleva, T., & Brenner, D. A. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.011 · Cited by 168 · see citing works
Kumar, V., Xin, X., Ma, J., Tan, C., Osna, N. A., & Mahato, R. I. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113888 · Cited by 164 · see citing works
Miethke, A. G., Zhang, W., Simmons, J., Taylor, A. E., Shi, T., Shanmukhappa, S. K., Karns, R., White, S., Jegga, A. G., Lages, C. S., et al. (2016) · Hepatology · doi:10.1002/hep.27973 · Cited by 141 · see citing works
Chen, M., Liu, J., Yang, W., & Ling, W. (2017) · Autophagy · doi:10.1080/15548627.2017.1356550 · Cited by 135 · see citing works
Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation
Poupon, R. (2015) · Hepatology · doi:10.1002/hep.27715 · Cited by 120 · see citing works
A Current Understanding of Bile Acids in Chronic Liver Disease
Farooqui, N., Elhence, A., & Shalimar, S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.08.017 · Cited by 91 · see citing works
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89 · see citing works
The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology
Li, B., Cai, S., & Boyer, J. L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166085 · Cited by 89 · see citing works
Self-citationThe interrelationship between bile acid and vitamin A homeostasis
Saeed, A., Hoekstra, M., Hoeke, M. O., Heegsma, J., & Faber, K. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.007 · Cited by 81 · see citing works
Vesterhus, M. N., & Karlsen, T. H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01681-z · Cited by 80 · see citing works
Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
Kumar, V., Mondal, G., Dutta, R., & Mahato, R. I. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.047 · Cited by 77 · see citing works
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
Weiskirchen, R., Weimer, J. P., Meurer, S. K., Kron, A., Seipel, B., Vater, I., Arnold, N., Siebert, R., Xu, L., Friedman, S. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075692 · Cited by 76 · see citing works
Drug Therapies for Chronic Cholestatic Liver Diseases
Wagner, M., & Fickert, P. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021059 · Cited by 72 · see citing works
Taylor, A. E., Carey, A. N., Kudira, R., Lages, C. S., Shi, T., Lam, S., Karns, R. A., Simmons, J. R., Shanmukhappa, K. S., Almanan, M., et al. (2018) · Hepatology · doi:10.1002/hep.30061 · Cited by 73 · see citing works
Yu, D., Zhang, C., Zhao, S., Zhang, S., Zhang, H., Cai, S., Shao, R., & He, H. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.155 · Cited by 72 · see citing works
Self-citationZhou, T., Drummen, G. P. C., & Qin, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010226 · Cited by 64 · see citing works
Li, T., Xu, L., Zheng, R., Wang, X., Li, L., Ji, H., & Hu, Q. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153153 · Cited by 56 · see citing works
The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?
Licata, A., Zerbo, M. K., Como, S., Cammilleri, M., Soresi, M., Montalto, G., & Giannitrapani, L. (2021) · Nutrients · doi:10.3390/nu13114014 · Cited by 54 · see citing works
Chen, P., Li, J., Fan, X., Zeng, H., Deng, R., Li, D., Huang, M., & Bi, H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.029 · Cited by 52 · see citing works
Xiao, W., Jiang, W., Shen, J., Yin, G., Fan, Y., Wu, D., Qiu, L., Yu, G., Xing, M., Hu, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141462 · Cited by 52 · see citing works
Ocular mucous membrane pemphigoid: a review
Taurone, S., Spoletini, M., Ralli, M., Gobbi, P., Artico, M., Imre, L., Czakó, C. N., Kovács, I., Greco, A., & Micera, A. (2019) · Immunologic Research · doi:10.1007/s12026-019-09087-7 · Cited by 49 · see citing works
Assis, D. N., Abdelghany, O., Cai, S., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M. M., Lindor, K. D., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000591 · Cited by 49 · see citing works
Self-citationLiver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
Lhotská, H., Chalupský, K., Zbodakova, O., Kanchev, I., Jiroušková, M., Gregor, M., & Sedláček, R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-155 · Cited by 49 · see citing works
Vitamin A Supplementation Alleviates Extrahepatic Cholestasis Liver Injury through Nrf2 Activation
Wang, G., Xiu, P., Li, F., Cheng, X., & Li, K. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/273692 · Cited by 47 · see citing works
Nuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45 · see citing works
Yu, D., Cai, S., Mennone, A., Vig, P., & Boyer, J. L. (2018) · Liver International · doi:10.1111/liv.13698 · Cited by 44 · see citing works
Self-citationWang, M., Li, J., Li, H., Dong, B., Jiang, J., Liu, N., Tan, J., Wang, X., Lei, L., Li, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.2139/ssrn.4065600 · Cited by 43 · see citing works
Meng, F., Kennedy, L. L., Hargrove, L. A., Demieville, J., Jones, H. F., Madeka, T., Karstens, A. W., Chappell, K., Alpini, G. D., Sybenga, A. B., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0101-0 · Cited by 43 · see citing works
Sierra-Mondragón, E., Rodríguez‐Muñoz, R., Namorado-Tónix, C., Molina‐Jijón, E., Romero-Trejo, D., Pedraza‐Chaverrí, J., & Reyes, J. L. (2019) · Biomolecules · doi:10.3390/biom9100525 · Cited by 43 · see citing works
A review of the medical treatment of primary sclerosing cholangitis in the 21st century
Goode, E. C., & Rushbrook, S. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315605821 · Cited by 41 · see citing works
Ahadome, S. D., Mathew, R., Reyes, N. S., Mettu, P. S., Cousins, S. W., Calder, V. L., & Saban, D. R. (2016) · JCI Insight · doi:10.1172/jci.insight.87012 · Cited by 41 · see citing works
An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis
Koop, A., Mousa, O. Y. S., Pham, L.-E., Corral-Hurtado, J. E., Pungpapong, S., & Keaveny, A. P. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7192 · Cited by 40 · see citing works
Halilbasic, E., Fuchs, C. D., Traussnigg, S., & Trauner, M. (2016) · Digestive Diseases · doi:10.1159/000445268 · Cited by 39 · see citing works
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
Ismail, M. H., & Pinzani, M. (2011) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s9051 · Cited by 38 · see citing works
Advances in understanding the regulatory mechanism of cholesterol 7α-hydroxylase.
Ge, M.-X., Shao, R., & He, H.-W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.008 · Cited by 34 · see citing works
Self-citationCai, S.-Y., Mennone, A., Soroka, C. J., & Boyer, J. L. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209353 · Cited by 36 · see citing works
Self-citationTreatment of primary sclerosing cholangitis
Floreani, A., & Martin, S. D. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.028 · Cited by 37 · see citing works
Vée, M. L., Jouan, E., Stieger, B., & Fardel, O. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.01.005 · Cited by 34 · see citing works
Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats
Zhen, Y., Li, N., He, H., Zhao, S., Zhang, G., Hao, X., & Shao, R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i23.7155 · Cited by 34 · see citing works
Self-citationTherapy of Primary Sclerosing Cholangitis - Today and Tomorrow
Halilbasic, E., Fuchs, C. D., Hofer, H., Paumgartner, G., & Trauner, M. (2015) · Digestive Diseases · doi:10.1159/000440827 · Cited by 33 · see citing works
TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a
Yang, Z., Zhang, H., Yin, M., Cheng, Z., Jiang, P., Feng, M., Liu, Z., & Liao, B. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02248-6 · Cited by 33 · see citing works
Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis
Lee, H. S., Jeong, H., Park, S., Yoo, W., Choi, S., Choi, K., Lee, M., Lee, M., Cha, D.-R., Kim, Y., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404527 · Cited by 33 · see citing works
Vitamin A deficiency in chronic cholestatic liver disease: Is vitamin A therapy beneficial?
Freund, C., & Gotthardt, D. (2017) · Liver international (Print) · doi:10.1111/liv.13433 · Cited by 27 · see citing works
Zhao, S., Li, N., Zhao, W., Liu, H., Ge, M., Zhang, Y., Zhao, L.-Y., You, X., He, H., & Shao, R. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.98 · Cited by 30 · see citing works
Self-citationAnticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis
Razori, M. V., Maidagán, P. M., Ciriaci, N., Andermatten, R. B., Barosso, I. R., Martín, P. L., Basiglio, C. L., Pozzi, E. J. S., Ruiz, M. L., & Roma, M. G. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.009 · Cited by 30 · see citing works
Advances in primary sclerosing cholangitis
Horsley‐Silva, J. L., Carey, E. J., & Lindor, K. D. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30010-3 · Cited by 30 · see citing works
Pathophysiologic role of hepatocyte nuclear factor 6
Wang, K., & Holterman, A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.009 · Cited by 28 · see citing works
Liu, C., Yang, Z., Wang, L., Lu, Y., Tang, B., Miao, H., Xu, Q., & Chen, X. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0380-5 · Cited by 28 · see citing works
RetractedMarzioni, M., Saccomanno, S., Agostinelli, L., Rychlicki, C., Minicis, S. D., Pierantonelli, I., Trauner, M. A., Fickert, P., Müller, T., Shanmukhappa, K. S., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.033 · Cited by 27 · see citing works
Zhang, L., Cheng, Y., Du, X., Chen, S., Feng, X., Gao, Y., Li, S., Liu, L., Yang, M., Chen, L., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/948376 · Cited by 26 · see citing works
Zhou, T., & Qin, Y. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.672992 · Cited by 26 · see citing works
Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis
Kartasheva-Ebertz, D., Pol, S., & Lagaye, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691073 · Cited by 24 · see citing works
Buko, V., Lukivskaya, O., Naruta, E. E., Belonovskaya, E., & Tauschel, H. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.02.001 · Cited by 23 · see citing works
External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort
Chapin, S. E., Goldberg, D. S., Kaplan, D. E., & Mahmud, N. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07307-5 · Cited by 23 · see citing works
Wen, S., Feng, S., Tang, S., Gao, J., Zhang, L.-H., Tong, H., Yan, Z., & Fang, D. Z. (2016) · Scientific Reports · doi:10.1038/srep35426 · Cited by 20 · see citing works
Gerussi, A., D’Amato, D., Cristoferi, L., O’Donnell, S. E., Carbone, M., & Invernizzi, P. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.09.009 · Cited by 20 · see citing works
Yao, F., Wang, X., Cao, X., Zhang, K., Sun, J. Y., Li, Y., Sui, J., & Liu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112177 · Cited by 20 · see citing works
Therapeutic Role of Bile Acids and Nuclear Receptor Agonists in Fibrosing Cholangiopathies
Trauner, M., Halilbasic, E., Kazemi-Shirazi, L., Kienbacher, C., Staufer, K., Traussnigg, S., & Hofer, H. (2014) · Digestive Diseases · doi:10.1159/000360517 · Cited by 19 · see citing works
New therapies target the toxic consequences of cholestatic liver disease
Jansen, P. L. M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1424538 · Cited by 19 · see citing works
Bull, L. N., Hu, D., Shah, S., Temple, L., Silva, K., Huntsman, S., Melgar, J., Geiser, M. T., Sanford, U. R., Ortiz, J. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131211 · Cited by 18 · see citing works
Liu, H., Wang, X., Deng, H., Huang, H., Liu, Y., Zhong, Z., Shen, L., Cao, S., Ma, X., Zhou, Z., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216086 · Cited by 16 · see citing works
Roles of the Lipid Metabolism in Hepatic Stellate Cells Activation
Jing, X.-Y., Yang, X., Qing, K., & Ouyang, Y. (2013) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(14)60008-0 · Cited by 15 · see citing works
Emerging treatments for primary sclerosing cholangitis
Rodríguez, E. A., Carey, E. J., & Lindor, K. D. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1293524 · Cited by 15 · see citing works
Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential
Xu, R., Zhang, L.-Y., Pan, H., & Zhang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1464655 · Cited by 14 · see citing works
Xu, S., Sun, A., & Suchy, F. J. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00138.2013 · Cited by 14 · see citing works
Xia, P., Deng, Q., Gao, J., Yu, X., Zhang, Y., Li, J., Guan, W., Hu, J., Tan, Q., Zhou, L., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.017 · Cited by 13 · see citing works
Sugiura, R., Ohnishi, S., Ohara, M., Ishikawa, M., Miyamoto, S., Onishi, R., Yamamoto, K., Kawakubo, K., Kuwatani, M., & Sakamoto, N. (2018) · Europe PMC (PubMed Central) · Cited by 13 · see citing works
Yang, H., Gu, J., Zhu, Q., Lu, H., Wang, K., Ni, X., Lu, Y., & Lu, L. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.042 · Cited by 12 · see citing works
Yuan, Z., Wang, G., Qu, J., Wang, X., & Li, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.001 · Cited by 12 · see citing works
González‐Rubio, S., Linares, C. I., Aguilar‐Melero, P., Rodríguez‐Perálvarez, M., Montero-Álvarez, J. L., de la Mata, M., & Ferrín, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160525 · Cited by 11 · see citing works
Ouziel, R., Trépo, E., Cremer, A., Moreno, C., Degré, D., Chaouni, M., Vercruysse, V., Quertinmont, E., Deviere, J. M., Lemmers, A., et al. (2013) · Liver International · doi:10.1111/liv.12249 · Cited by 10 · see citing works
Advances in understanding the regulatory mechanism of organic solute transporter α-β
Lu, Z.-N., He, H., & Zhang, N. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121109 · Cited by 10 · see citing works
Self-citationFuture Medical Treatment of PSC
Krones, E., Marschall, H., & Fickert, P. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00454-4 · Cited by 9 · see citing works
Park, J. H., Kim, J., Choi, S.-Y., Lee, B., Lee, J. E., Park, H., Moon, J. W., Park, S., Lee, J. M., Lee, H. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82758-4 · Cited by 8 · see citing works
Hassan, H. M., Safadi, M. E., Mustfa, W., Tehreem, S., Antoniolli, G., Mehreen, A., Ali, A., & Al‐Emam, A. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102635 · Cited by 6 · see citing works
Frano, M. R. L., Alex Brito, O., Johnson, C., Wilhelmson, B., Gannon, B. M., Fanter, R. K., Pedersen, T. L., Tanumihardjo, S. A., & Newman, J. W. I. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901319 · Cited by 6 · see citing works
Magnesium chenoursodeoxycholic acid ameliorates carbon tetrachloride-induced liver fibrosis in rats
Kang, J., Yoon, S., Sung, Y.-K., & Lee, S. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011219 · Cited by 6 · see citing works
Therapeutic Effect of Glycyrrhizin Arginine Salt on Rat Cholestatic Cirrhosis and its Mechanism
Zhang, H., Lin, Y., Zhen, Y., Hu, G., Meng, X., Li, X., & Men, X. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500581 · Cited by 6 · see citing works
Wang, Y., Wang, H., Li, Q., Zhang, Y., Dai, R., Wu, J., Zhang, Y., Zhang, X., Zhao, L., & Liu, J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00259 · Cited by 4 · see citing works
Nutritional Management of Hepatobiliary Diseases in Dogs and Cats
Stockman, J. A. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.03.007 · Cited by 4 · see citing works
Altered Expression of Retinol Metabolism-Related Genes in an ANIT-Induced Cholestasis Rat Model
Takitani, K., Kishi, K., Miyazaki, H., Koh, M., Tamaki, H., Inoue, A., & Tamai, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113337 · Cited by 3 · see citing works
Zhang, N., Niu, W., Niu, W., Li, Y., Guo, S., Li, Y., He, W., & He, H. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101048 · Cited by 3 · see citing works
Self-citationBadr, A. M., Farid, M., Biomy, A. A. A., Mohamed, A. S., Mahana, N. A., & Fahmy, S. R. (2020) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-020-00197-5 · Cited by 3 · see citing works
Gunay, Y., Altaner, Ş., & Ekmen, N. (2014) · Gastroenterology Research and Practice · doi:10.1155/2014/564949 · Cited by 3 · see citing works
Review of pharmacotherapeutic treatments for primary sclerosing cholangitis
Zhang, C., Hussaini, T., & Yoshida, E. M. (2019) · Canadian Liver Journal · doi:10.3138/canlivj-2018-0016 · Cited by 3 · see citing works
GADALLAH, H. N. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.116830 · Cited by 2 · see citing works
Sawada, N., Mikami, K., Igarashi, G., Endo, T., Sato, K., Kakizaki, I., & Fukuda, S. (2016) · Institutional Repositories DataBase (IRDB) · Cited by 2 · see citing works
Pathophysiologic Basis for Alternative Therapies for Cholestasis
Fuchs, C. D., Halilbasic, E., & Trauner, M. A. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch30 · Cited by 2 · see citing works
[Potential targets for anti-liver fibrosis].
Zhao, S., Shao, R., & He, H. (2014) · PubMed · Cited by 1 · see citing works
Self-citationEffect of gallic acid on liver injury during obstructive cholestasis after bile duct ligation in rat
Basuguy, E., Okur, M. H., Arslan, S., Zeytun, H., Aydoğdu, G., & Ekinci, A. (2021) · Experimental Biomedical Research · doi:10.30714/j-ebr.2021165781 · Cited by 1 · see citing works
C6orf120 Deficiency Inhibits Hepatic Stellate Cell Activation by Upregulating RARβ Signaling
Lin, Y., Wang, X., Cui, X., Zhu, N., Li, Y., & Li, X. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01682-w · Cited by 1 · see citing works
Yeh, Y., Lin, N., Yeh, Y., Tsai, H.-L., Chen, C., Liu, C.-P., & Liu, C. (2018) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2018.08.033 · Cited by 1 · see citing works
Hoeke, M. O. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1 · see citing works
Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.Preprint
Kudira, R., Yang, Z. F., Osuji, I., Karns, R. A., Bariya, P., Pfuhler, L., Mullen, M. M., Taylor, A. E., Ji, H., Lages, C. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.17.594680 · Cited by 1 · see citing works
The effect of lipid metabolism on biological characteristics of hepatic stellate cell
Jing, X.-Y., & Yang, X. (2013) · 中国人民解放军军医大学学报：英文版 · doi:10.1016/s1000-1948(13)60044-1
- Authors
- He, H., Mennone, A., Boyer, J. L., & Cai, S.-Y.
- Affiliations
- Yale University (US)
- Corresponding author
- Boyer, James L.
- Cai, Shi-Ying
- Venue
- Hepatology
- Published
- 2010-12-10
- Volume
- 53
- Issue
- 2
- Pages
- 548-557
- ISSN
- 0270-9139 (ISSN-L)
- PMC
- PMC3069505
- OpenAlex
- W2089117732
- Cited by
- 119
- References
- 38
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 7 · 2023: 1 · 2022: 3 · 2021: 11 · 2020: 5 · 2019: 12 · 2018: 12 · 2017: 6 · 2016: 9 · 2015: 16 · 2014: 7 · 2013: 13 · 2012: 4
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Liver Foundation
- Yale University
- National Institutes of Health (#N01‐DK‐7–0004/HHSN267200700004C, HHSN267200700004C, DK25636, DK34989)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK025636, R37DK025636, DK-34989, P30DK034989, DK 25636)
- U.S. National Library of Medicine (HHSN267200700004C, HHSN267200700004G)
- Yale Liver Center (DK34989)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- retinoic acid, ursodeoxycholic acid, cholestasis, liver fibrosis, bile duct ligation, liver injury, hepatic stellate cells, hepatocytes, TGF-β1 signaling, Smad2 phosphorylation, collagen expression, MMP-2, CYP7A1, combination therapy
- MeSH terms
- Collagen Type I, alpha 1 Chain, Animals, Bile Acids and Salts, Bile Ducts, Cells, Cultured, Cholestasis, Intrahepatic, Cholesterol 7-alpha-Hydroxylase, Disease Models, Animal, Humans, Ligation, Liver, Male, Tretinoin, Ursodeoxycholic Acid, Rats, Sprague-Dawley, Matrix Metalloproteinase 2, Hepatocytes, Collagen Type I, Cell Proliferation, Rats, Smad2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
